• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: QUEST DIAGNOSTICS HAIR OF ABUSE DRUG TEST LDT; LABORATORY DEVELOPED TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

QUEST DIAGNOSTICS HAIR OF ABUSE DRUG TEST LDT; LABORATORY DEVELOPED TEST Back to Search Results
Model Number 37004N
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2024
Event Type  malfunction  
Event Description
I took a hair test collected in (b)(6) and sent to kansas lab- quest diagnostics.On the labs website it states cutoff was 500pg and confirmation 500pg.The test i took was initial cutoff 500pg and confirmation 250pg.Additionally the chain of custody was inaccurate as the test has no collection time and their is no shipping and transport information.These tests need to be regulated or taken off the market.
 
Event Description
Additional information received on 5/23/2024 for report mw5152465 to update manufacturer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HAIR OF ABUSE DRUG TEST LDT
Type of Device
LABORATORY DEVELOPED TEST
Manufacturer (Section D)
QUEST DIAGNOSTICS
MDR Report Key18858211
MDR Text Key337371145
Report NumberMW5152465
Device Sequence Number1
Product Code OQS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number37004N
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/06/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/23/2024
Patient Sequence Number1
Treatment
ADDERALL .; MUCINEX D.; TAMIFLU.
Patient Outcome(s) Other;
Patient Age44 YR
Patient SexFemale
Patient Weight46 KG
Patient EthnicityNon Hispanic
Patient RaceAmerican Indian Or Alaskan Native
-
-